CANTANHEDE, Portugal–(BUSINESS WIRE)–Tilray,
a GMP-certified global leader in medical cannabis research and
production, today announced that the company has successfully exported
live medical cannabis genetics from its flagship British Columbia,
Canada facility to its European Union Campus in Cantanhede, Portugal.
The announcement is the first time a company has legally exported live
cannabis genetics from North America to Europe and marks another
strategic milestone as Tilray develops its EU Campus into the region’s
leading medical cannabis research and production facility.
“Tilray is proud to bring our